BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Matsumoto Y, Ohyama A, Kubota T, Ikeda K, Kaneko K, Takai Y, Warita H, Takahashi T, Misu T, Aoki M. MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review. Front Neurol 2022;13:845755. [PMID: 35299613 DOI: 10.3389/fneur.2022.845755] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Weidauer S, Zeitz A, Tafreshi M, Hattingen E, Arendt C. Acute Disseminated Encephalomyelitis and Acute Encephalitis Following Vaccination Against SARS-CoV-2: Two Case Reports and Review of Literature. Fortschr Neurol Psychiatr 2023. [PMID: 36931294 DOI: 10.1055/a-2029-4405] [Reference Citation Analysis]
2 Nakano H, Yamaguchi K, Hama N, Matsumoto Y, Shinohara M, Ide H. Relapsing Anti-MOG Antibody-associated Disease following COVID-19 Vaccination: A Rare Case Report and Review of the Literature. Intern Med 2023;62:923-8. [PMID: 36575011 DOI: 10.2169/internalmedicine.0504-22] [Reference Citation Analysis]
3 Kim S, Seok HY. Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD. Neurol Sci 2023. [PMID: 36781562 DOI: 10.1007/s10072-023-06676-1] [Reference Citation Analysis]
4 Arismendez AA, Chopra J, Campbell T, Balsiger R, Vickers A. New-onset MOGAD after first-dose SARS-CoV-2 mRNA vaccination with relapse following SARS-CoV-2 mRNA booster. Can J Ophthalmol 2023:S0008-4182(23)00034-0. [PMID: 36803930 DOI: 10.1016/j.jcjo.2023.01.013] [Reference Citation Analysis]
5 Jacobs J, Vu P, Liu AK. A Patient With Myelin Oligodendrocyte Glycoprotein Positive Encephalitis With Ring Enhancing Lesions on Magnetic Resonance Imaging (MRI) After COVID-19 Exposure. Cureus 2022. [DOI: 10.7759/cureus.31844] [Reference Citation Analysis]
6 Finsterer J, Scorza FA. Comment on 'MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report'. Ther Adv Neurol Disord 2022;15:17562864221106363. [PMID: 35769630 DOI: 10.1177/17562864221106363] [Reference Citation Analysis]
7 Mouliou DS, Dardiotis E. Current Evidence in SARS-CoV-2 mRNA Vaccines and Post-Vaccination Adverse Reports: Knowns and Unknowns. Diagnostics 2022;12:1555. [DOI: 10.3390/diagnostics12071555] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
8 Jarius S, Bieber N, Haas J, Wildemann B. MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature. J Neurol 2022. [PMID: 35737110 DOI: 10.1007/s00415-022-11194-9] [Reference Citation Analysis]
9 Nagahata K, Suzuki S, Yokochi R, Nei Y, Hagino N. Recurrent Optic Perineuritis With Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease Complicated With Granulomatous Polyangiitis. Cureus. [DOI: 10.7759/cureus.25239] [Reference Citation Analysis]
10 . Elasomeran. Reactions Weekly 2022;1903:169-169. [DOI: 10.1007/s40278-022-13731-0] [Reference Citation Analysis]